C12Q 2563/161
Vesicles
Official title: Vesicles, e.g. liposome
C12Q2563/161 (Vesicles) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12Q- Granted patents
- 3
- Published applications
- 6
- Assignees
- 5
- Inventors
- 17
- Latest grant
- 11 Oct 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 2 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for concentrating extracellular vesicles11 Oct 2022US 11,467,073 B2Sysmex Corporation
- Barcode-free single vesicle multiplexed protein and RNA analysis16 Aug 2022US 11,414,699 B2Mantra Bio, Inc.
- Liposomes for in-vivo delivery23 May 2017US 9,655,848 B2Technion Research & Development Foundation Limited
- Compositions containing oligonucleotides with theranostic applications16 Jul 2026US 2026/0201363 A1Sixfold Bioscience Ltd.
- Extraction-less reverse phase (rp) chromatography of mrna encapsulated in lipid nanoparticles for mrna purity assessment20 Mar 2025US 2025/0092440 A1ModernaTX, Inc.
- Barcode-free single vesicle multiplexed protein and rna analysis1 Sep 2022US 2022/0275441 A1Mantra Bio, Inc.
- Barcode-free single vesicle multiplexed protein and rna analysis21 Nov 2019US 2019/0352708 A1Mantra Bio, Inc.
- Method for concentrating extracellular vesicles27 Sep 2018US 2018/0275029 A1Sysmex Corporation
Most cited
By later US patents